Stock Alert: ADMA Biologics Jumps 37%

Shares of ADMA Biologics, Inc. (ADMA) are currently gaining over 37% on Thursday morning despite no stock related news to drive the shares.

U.S. stocks traded sharply lower on Thursday morning, as investors are pessimistic about economic rebound due to spike in COVID-19 cases. Meanwhile, shares of pharma companies are performing better lately driven by the positive reports of COVID-19 vaccine.

ADMA is currently trading at $3.8927, up $1.0527 or 37.07%, on the Nasdaq. The stock has traded between $1.45 and $4.65 in the year-to-date period.

ADMA Biologics will release its second quarter financial results on August 5.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Company (GE) said it delivered a strong third quarter as orders grew, and margins continued to improve from a year ago. Adjusted GE Industrial organic profit increased 54% year-on-year, organically, driven primarily by increases at Aviation and Power, partially offset by decreases at... Ward Hill, Massachusetts-based Cedar's Mediterranean Foods is recalling Cedar's Organic Mediterranean Hommus citing undeclared pine nut, an allergen, the U.S. Food and Drug Administration said. The Cedar's Organic Mediterranean Hommus is packaged in a 10 oz. plastic container, with a UPC Code: 044115403028. Shares of UBS Group AG were gaining around 2 percent in Swiss trading after the banking major reported Tuesday higher profit in its third quarter with growth in net interest income. Further, the company said it intends to repurchase up to $0.6 billion of shares during the fourth quarter. The company will provide strategic update on February 1, 2022.
Follow RTT